Literature DB >> 9507744

Semen analysis and antisperm antibody.

M Kamada1, S Yamano, M Senuma, K Nakagawa, M Maegawa, T Aono.   

Abstract

Evaluation of the fertilizing potential of sperm is an important procedure in in vitro fertilization and embryo transfer (IVF-ET) clinic, in order to avoid performing invalid conventional IVF-ET or unnecessary intracytoplasmic sperm injection (ICSI). However, none of the standard semen parameters are reliable indices in predicting IVF outcome. The test examining sperm-zona interaction is the best present method, though the short supply of the human zona component should be solved. IVF-ET treatment is useful for pregnancy in women having sperm immobilizing antibodies because it avoids exposing sperms to antibodies that block fertilization. ICSI should be used in immunologically infertile men diagnosed by specific method to demonstrate the in vivo exposure of sperms to antisperm autoantibodies that block fertilization.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9507744     DOI: 10.3109/01485019808987934

Source DB:  PubMed          Journal:  Arch Androl        ISSN: 0148-5016


  3 in total

Review 1.  Cutting-edge issues in autoimmune orchitis.

Authors:  Clovis A Silva; Marcello Cocuzza; Eduardo F Borba; Eloísa Bonfá
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 2.  Sperm-zona pellucida interaction and immunological infertility.

Authors:  Masaharu Kamada; Masahiko Maegawa; Toshihumi Daitoh; Kazumasa Mori; Satoshi Yamamoto; Koji Nakagawa; Syuji Yamano; Minoru Irahara; Toshihiro Aono; Takahide Mori
Journal:  Reprod Med Biol       Date:  2006-05-19

3.  Selected Risk Factors and Pattern of Semen Abnormality in Male Partners of Infertile Couples in Eastern Nepal: A Descriptive Cross-sectional Study.

Authors:  Sita Pokhrel; Ashima Ghimire; Manisha Chhetry; Sabina Lamichane; Rupesh Kumar Shreewastav
Journal:  JNMA J Nepal Med Assoc       Date:  2020-09-27       Impact factor: 0.406

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.